The Value of a PBM Partnership

Employers, unions, state governments, health systems, public sector retirees and others work with pharmacy benefit managers (PBMs) to offer private sector solutions that deliver value to the health care system, address rising drug costs, and keep patients healthy.

Deliver Value for the Health Care System

Providing programs and services that lower costs and reduce wasteful spending on health care

Creating Long-Term Savings

Lowering costs and increasing access

PBMs WILL SAVE A TOTAL OF

—up to 30%—on prescription drug
benefit costs over the next decade1

Deploying Sophisticated Analytical Tools and Data

Helping partners make clinically-driven decisions to best address the health needs of patients and workers


Address Rising Prescription Drug Costs

Ensuring sustainable access to affordable and effective prescription drugs

NEGOTIATING FOR AFFORDABLE ACCESS

Negotiating discounts from drug manufacturers


PROMOTING COMPETITION TO REDUCE COSTS

Leveraging private sector competition to promote affordable access



IMPROVING ACCESS TO GENERICS AND BIOSIMILARS

Promoting patient access to lower cost, clinically-effective generics and biosimilars


Keep Patients Healthy

Providing patients with the timely information and tools needed to improve their health and effectively manage chronic conditions

PROMOTING PATIENT SAFETY

Using deep clinical expertise to help patients avoid potential drug interactions

PBMs HELP PREVENT

prescription errors a year by:5

MEDICATION ADHERENCE TOOLS

Coordinated patient-focused programs that increase prescription drug adherence

HOSPITAL RE-ADMISSIONS ARE RELATED TO ADVERSE MEDICATION EVENTS RESULTING FROM NONADHERENCE6

OFFERING CONVENIENT ACCESS

Providing the choice of home delivery or pharmacy pick up

HELPING PEOPLE MORE EASILY ACCESS
THE MEDICINES THEY NEED TO

Stay Healthy

References:

1 Visante (Feb. 2016). “Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers” http:/thatswhatpbmsdo.com/wp-content/uploads/2016/02/visante-pbm-savings-study-Feb-2016.pdf
2 Visante (Feb. 2016). “Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers” http:/thatswhatpbmsdo.com/wp-content/uploads/2016/02/visante-pbm-savings-study-Feb-2016.pdf
3 Quintiles IMS Institute: “Medicines Use and Spending in the U.S.: A Review of 2016 and Outlook to 2021.” Page 4. May 2017.”http://www.imshealth.com/en/thought-leadership/quintilesims-institute/reports/medicines-use-and-spending-in-the-us-review-of-2016-outlook-to-2021
4 Generic Pharmaceutical Association (Oct.19,2016).“2016 Generic Drug Savings & Access in the United States Report.” http:/www.gphaonline.org/media/generic-drug-savings-2016/index.html
5 Visante (Nov.2016) “The Return on Investment (ROI) on PBM Services.” https://www.pcmanet.org/wp-content/uploads/2016/11/ROI-on-PBM-Services-FINAL.pdf
6 NCBI (Sept.,2002). “Hospital admissions resulting from preventable adverse drug reactions.” https://www.ncbi.nlm.nih.gov/pubmed/12196047